Alyeska Investment Group
OPTN

Alyeska Investment Group’s OptiNose OPTN Stock Holding History

Alyeska Investment Group’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,000
Closed -$2.83M – 494
2017
Q4 		$2.83M Buy
+10,000
New +$2.81M 0.02% 304

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Alyeska Investment Group's OPTN Position: Q1 2018 in Review

Alyeska Investment Group sold out of OptiNose (OPTN) in Q1 2018, closing a stake of 10,000 shares — an estimated $2.83M sold.

Alyeska Investment Group first reported a position in OPTN in Q4 2017 and held it in 1 quarter. The position peaked at $2.83M in Q4 2017. 49 funds tracked by Wall St. Rank hold OPTN as of Q1 2018.

  • Alyeska Investment Group reported no remaining OptiNose position as of Q1 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 10,000 OptiNose shares in Q1 2018, an estimated $2.83M.
  • Alyeska Investment Group first reported a position in OptiNose in Q4 2017 and held it in 1 quarter.
  • Alyeska Investment Group's OptiNose position peaked at $2.83M in Q4 2017.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q1 2018.

Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.